EUVIMEDAtrasti EUVIMED
Klinische Studie (Phase I)

Intracerebral transplantation of autologous adipose‐derived stem cells for chronic ischemic stroke: A phase I study

Tsung-Lang Chiu, Rathinasamy Baskaran, Sheng-Tzung Tsai, Chih-Yang Huang, Ming-Hsi Chuang, Wan-Sin Syu, Horng-Jyh Harn, Yi-Chun Lin, Chun-Hung Chen, Pi-Chun Huang, Yi-Fen Wang, Chi-Hsuan Chuang and 2 more

Journal of Tissue Engineering and Regenerative Medicine · 2022-01 · 16 (1) · 3-13

DOI: 10.1002/term.3256 ↗

At a glance

Klinische Studie (Phase I) in Journal of Tissue Engineering and Regenerative Medicine, published online on 2021-10-21. Written by Tsung-Lang Chiu and 13 co-authors. Institution: Department of Neurosurgery, Bioinnovation Center, Tzu Chi Foundation, Buddhist Tzu Chi General Hospital, Tzu Chi University, Hualien, Taiwan, ROC. Major MEDLINE topics: Ischemic Stroke, Mesenchymal Stem Cell Transplantation, Stroke. Cited 37 times so far (Crossref); 44 references. Funded by: Gwo Xi.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Current therapy does not provide significant benefits for patients with chronic stroke. Pre-clinical studies suggested that autologous adipose-derived stem cells have benefits for the treatment of chronic stroke. This Phase I open-label study was conducted to demonstrate the safety and efficacy of autologous adipose-derived stem cells (GXNPC1) in chronic stroke. Three patients with chronic stroke were treated with stereotactic implantation of autologous adipose-derived stem cells (1 × 108 cells). The primary endpoints of safety evaluation included adverse events, over a 6 months post-implantation period. The secondary endpoints included improvements in neurological functions. Evolutional change of brain parenchyma was also followed with magnetic resonance imaging (MRI). All three participants improved significantly at 6 months follow-up. The extent of improvement from pre-treatment was: National Institutes of Health Stroke Scale improved 5-15 points, Barthel Index: 25-50 points, Berg balance scale 0-21 points and Fugl-Meyer modified sensation 3-28 points. All three patients had signal change along the implantation tract on MRI one month after surgery. There is no related safety issue through 6 months observation. Clinical measures of neurological symptoms of these patients with chronic stroke improved at 6 months without adverse effects after implantation of autologous adipose-derived stem cells (GXNPC1), which might be correlated with post-implantation changes on brain MRI. Clinical Trial Registration-URL: https://clinicaltrials.gov/ct2/show/NCT02813512?term=ADSC&cond=Stroke&cntry=TW&draw=2&rank=1 Unique identifier: NCT02813512.

Subjects

MeSH terms (MEDLINE)

Ischemic StrokeMesenchymal Stem Cell TransplantationStrokeAdipose TissueHumansTransplantation, AutologousTreatment Outcome

Author keywords

adipose derived stem cellcell therapychronic strokeclinical trialstereotactic implantation

Authors and institutions

  • Department of Neurosurgery, Bioinnovation Center, Tzu Chi Foundation, Buddhist Tzu Chi General Hospital, Tzu Chi University, Hualien, Taiwan, ROC.
  • Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan, ROC.
  • Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, ROC.
  • Department of Biological Science and Technology, Asia University, Taichung, Taiwan, ROC.
  • Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan, ROC.
  • Department of Technology Management, Chung Hwa University, Hsinchu, Taiwan, ROC.

Funding

  • Gwo Xi

Cite

APA

Chiu, T. L., Baskaran, R., Tsai, S. T., Huang, C. Y., Chuang, M. H., Syu, W. S., Harn, H. J., Lin, Y. C., Chen, C. H., Huang, P. C., Wang, Y. F., Chuang, C. H., Lin, P. C., & Lin, S. Z. (2022). Intracerebral transplantation of autologous adipose‐derived stem cells for chronic ischemic stroke: A phase I study. Journal of Tissue Engineering and Regenerative Medicine, 16(1), 3-13. https://doi.org/10.1002/term.3256

Vancouver

Chiu TL, Baskaran R, Tsai ST, Huang CY, Chuang MH, Syu WS, et al. Intracerebral transplantation of autologous adipose‐derived stem cells for chronic ischemic stroke: A phase I study. Journal of Tissue Engineering and Regenerative Medicine. 2022;16(1):3-13. doi:10.1002/term.3256

BibTeX
@article{Chiu2022,
  author = {Chiu, Tsung-Lang and Baskaran, Rathinasamy and Tsai, Sheng-Tzung and Huang, Chih-Yang and Chuang, Ming-Hsi and Syu, Wan-Sin and Harn, Horng-Jyh and Lin, Yi-Chun and Chen, Chun-Hung and Huang, Pi-Chun and Wang, Yi-Fen and Chuang, Chi-Hsuan and Lin, Po-Cheng and Lin, Shinn-Zong},
  title = {Intracerebral transplantation of autologous adipose‐derived stem cells for chronic ischemic stroke: A phase I study},
  journal = {Journal of Tissue Engineering and Regenerative Medicine},
  year = {2022},
  volume = {16},
  number = {1},
  pages = {3--13},
  doi = {10.1002/term.3256}
}
Start for free →